Weekly Quick Hits (BHCR) – Week of July 24, 2023

Published on :

Children’s Cancer Foundation Awards went out to 11 pediatric cancer researchers in the Baltimore-Washington region, and a number of companies reported their quarterly finances. It was a busy week for life science news in the Capital Region. Here’s a look.

Weekly Quick Hits (BioHealth Capital Region) – Week of July 17, 2023

Published on :

A strong revenue stream is essential for thriving biopharma companies. Despite a struggling economy, several companies within the BioHealth Capital Region are successfully raising capital to support development of new therapeutics for multiple disorders, while others continue to advance their own experimental assets. 

Weekly Quick Hits (BioHealth Capital Region) – Week of January 23, 2023

Published on :

Here’s what’s been happening the BioHealth Capital Region’s Life Science scene the week of January 23, 2023

BioHealth Capital Region Eyes Continued Growth in 2023, Charts New Goals Amidst Tough Economic Headwinds

Published on :

That’s the assessment of Rich Bendis, President and Chief Executive Officer of BHI, who has championed the region’s transition into a top four biopharma hub in the United States. However, given the state of the economy and the amount of money being invested, Bendis said it is unrealistic to expect the region to move up the ranking of the top 10 life sciences regions compiled by Genetic Engineering & Biotechnology News (GEN).

In Conversation: Dr. Amrie Grammer, Co-founder, President and Chief Scientific Officer, AMPEL Biosolutions

Amrie Grammer
Published on :

AMPEL Biosolutions (AMPEL), located in Charlottesville, Virginia is a leading personalized precision medicine company developing tools that can help autoimmune and inflammatory disease patients improve their quality of life. AMPEL is one of the exciting companies that have emerged from the Charlottesville (CVille) biohub clustered around the University of Virginia (UVA). 

Industry Leaders Share Optimism on the Region’s Life Sciences Economic Outlook Amid Recession Concerns

Published on :

To discuss how the Biohealth Capital Region would fare out in a potential recession, and whether it can actually avoid one, the I-270 Innovation Labs brought together an outstanding group of regional experts from across key sectors connected to both industries.

Neuroene Therapeutics Wins 7th Annual Crab Trap Competition

Neuroene Therapeutics standing with Rich Bendis of BioHealth Innovations, holding a giant check
Published on :

Gaithersburg-based Neuroene Therapeutics and its approach to treating a rare form of epilepsy was crowned the winner of the seventh annual Crab Trap Competition, which highlights the commercialization potential of biohealth technologies throughout the BioHealth Capital Region. 

BioHealth Capital Region Forum 2022 Preview

Published on :

There is no better way to get a glimpse into the future of the region’s life sciences ecosystem than the 8th annual BioHealth Capital Region (BHCR) Forum, which is fast approaching. The 2022 BHCR Forum is a can’t miss in-person/live streamed event hosted at United States Pharmacopeia (USP) in Rockville, Maryland on September 20th. Also, on September 21st at USP will be the  5th Annual BioHealth Capital Region Investment Conference and the 7th Annual Crab Trap Competition. 

BioHealth Capital Region Forum Crab Trap Winners: Where Are They Now?

Published on :

The Crab Trap competition brings together entrepreneurs with innovative diagnostics, medical devices, therapeutics or other transformative health solutions to compete for a prize package valued at $50,000, which includes cash rewards and a one-year residency at JLABS @ Washington DC. Crab Trap finalists will earn the chance to make an in-person pitch at the BioHealth Region Investment Conference.